The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
Open accessAbstract
An enzymatic synthesis may ultimately offer a more efficient means of producing an important class of anticoagulant drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A modified uronic acid carbazole reaction
Bitter, T., & Muir, H. M. (1962) · Analytical Biochemistry · doi:10.1016/0003-2697(62)90095-7 · Cited by 6,274
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,857
Triggers, targets and treatments for thrombosis
Mackman, N. (2008) · Nature · doi:10.1038/nature06797 · Cited by 1,188
Regulated Diversity of Heparan Sulfate
Lindahl, U., Kusche-Gullberg, M., & Kjellén, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.24979 · Cited by 678
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
Guerrini, M., Beccati, D., Shriver, Z., Naggi, A., Viswanathan, K., Bisio, A., Capila, I., Lansing, J. C., Guglieri, S., Fraser, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1407 · Cited by 628
Self-citationA Synthetic Antithrombin III Binding Pentasaccharide Is Now a Drug! What Comes Next?
Petitou, M., & van Boeckel, C. A. A. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300640 · Cited by 485
Lessons learned from the contamination of heparin
Liu, H., Zhang, Z., & Linhardt, R. J. (2009) · Natural Product Reports · doi:10.1039/b819896a · Cited by 396
Self-citationBeyond Unfractionated Heparin and Warfarin: Current and Future Advances
Hirsh, J., O’Donnell, M., & Eikelboom, J. W. (2007) · Circulation · doi:10.1161/circulationaha.106.685974 · Cited by 211
Solution Structures of Chemoenzymatically Synthesized Heparin and Its Precursors
Zhang, Z., McCallum, S. A., Xie, J., Nieto, L., Corzana, F., Jiménez-Barbero, J., Chen, M., Liu, J., & Linhardt, R. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8026345 · Cited by 168
Self-citationEnzymatic synthesis of antithrombin III–binding heparan sulfate pentasaccharide
Kuberan, B., Lech, M., Beeler, D. L., Wu, Z. L., & ROSENBERG, R. D. (2003) · Nature Biotechnology · doi:10.1038/nbt885 · Cited by 168
Chemoenzymatic Design of Heparan Sulfate Oligosaccharides*
Liu, R., Xu, Y., Chen, M., Weïwer, M., Zhou, X., Bridges, A. S., DeAngelis, P. L., Zhang, Q., Linhardt, R. J., & Liu, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159152 · Cited by 164
Self-citationAnticoagulant heparan sulfate: structural specificity and biosynthesis
Liu, J., & Pedersen, L. C. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0722-x · Cited by 157
Self-citationLee, M. K., & Lander, A. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2768 · Cited by 151
Edens, R. E., Al-Hakim, A. H., Weiler, J. M., Rethwisch, D. G., Fareed, J., & Linhardt, R. J. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810821 · Cited by 150
Self-citationE. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor
Wang, Z., Ly, M., Zhang, F., Zhong, W., Suen, A., Hickey, A. M., Dordick, J. S., & Linhardt, R. J. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22898 · Cited by 133
Self-citationLoganathan, D., Wang, H. M., Mallis, L. M., & Linhardt, R. J. (1990) · Biochemistry · doi:10.1021/bi00470a015 · Cited by 130
Self-citationEnzymatic Redesigning of Biologically Active Heparan Sulfate
Chen, J., Avci, F. Y., Muñoz, E. M., McDowell, L. M., Chen, M., Pedersen, L. C., Zhang, L., Linhardt, R. J., & Liu, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504338200 · Cited by 127
Self-citationGeneration of “Neoheparin” from E. coli K5 Capsular Polysaccharide
Lindahl, U., Li, J., Kusche‐Gullberg, M., Salmivirta, M., Alaranta, S., Veromaa, T., EMEIS, J. J., Roberts, I. S., Taylor, C. M., Oreste, P., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049812m · Cited by 124
Regeneration of PAPS for the Enzymatic Synthesis of Sulfated Oligosaccharides
Burkart, M. D., Izumi, M., Chapman, E., Lin, C., & Wong, C. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo000266o · Cited by 114
Using an Enzymatic Combinatorial Approach to Identify Anticoagulant Heparan Sulfate Structures
Chen, J., Jones, C. L., & Liu, J. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.07.015 · Cited by 109
Self-citationChemoenzymatic Synthesis with Distinct Pasteurella Heparosan Synthases
Sismey-Ragatz, A. E., Green, D. E., Otto, N. J., Rejzek, M., Field, R. A., & DeAngelis, P. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701599200 · Cited by 101
Design of biologically active heparan sulfate and heparin using an enzyme-based approach
Peterson, S. B., Frick, A., & Liu, J. (2009) · Natural Product Reports · doi:10.1039/b803795g · Cited by 99
Self-citationZhou, X., Chandarajoti, K., Pham, T. Q., Liu, R., & Liu, J. (2011) · Glycobiology · doi:10.1093/glycob/cwr001 · Cited by 94
Self-citationZhang, L., Beeler, D. L., Lawrence, R., Lech, M., Liu, J., Davis, J., Shriver, Z. H., Sasisekharan, R., & ROSENBERG, R. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101441200 · Cited by 88
Self-citationBeyond heparin and warfarin: the new generation of anticoagulants
Weitz, J. I., & Linkins, L. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.3.271 · Cited by 73
Duncan, M. B., Chen, J., Krise, J. P., & Liu, J. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2003.12.010 · Cited by 42
Self-citationWang, Z., Yang, Z., He, X., Kamal, B. E., & Xing, Z. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22862 · Cited by 27
Potential of new anticoagulants in patients with cancer
Weitz, J. I. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70009-8 · Cited by 20
In Vivo Models for the Evaluation of Antithrombotics and Thrombolytics
Mousa, S. A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-803-4_2 · Cited by 15
Self-citationNew challenges for a second-generation low-molecular-weight heparin: focus on bemiparin
Martínez‐González, J., & Rodrı́guez, C. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.35 · Cited by 13
Cited by
Demystifying Heparan Sulfate–Protein Interactions
Xu, D., & Esko, J. D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035314 · Cited by 805
Glycosaminoglycans: key players in cancer cell biology and treatment
Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D., Pavão, M. S., Tzanakakis, G. N., & Karamanos, N. K. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08529.x · Cited by 554
Green Solvents in Carbohydrate Chemistry: From Raw Materials to Fine Chemicals
Farrán, A., Cai, C., Sandoval, M., Xu, Y., Liu, J., Hernáiz, M. J., & Linhardt, R. J. (2015) · Chemical Reviews · doi:10.1021/cr500719h · Cited by 393
Self-citationHeparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications
Liang, Y., & Kiick, K. L. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.07.031 · Cited by 349
Pharmacology of Heparin and Related Drugs
Mulloy, B., Hogwood, J., Gray, E., Lever, R., & Page, C. P. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011247 · Cited by 341
Metadata
- Authors
- Xu, Y., Masuko, S., Takieddin, M., Xu, H., Liu, R., Jing, J., Mousa, S. A., Linhardt, R. J., & Liu, J.
- Venue
- Science
- Published
- 2011-10-28
- Volume
- 334
- Issue
- 6055
- Pages
- 498-501
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2025006097
- Cited by
- 407
- References
- 30
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.